Literature DB >> 12071873

Study of five cell salvage machines in coronary artery surgery.

J F Burman1, A S Westlake, S J Davidson, L C Rutherford, A S Rayner, A M Wright, C J Morgan, J R Pepper.   

Abstract

We evaluated the effectiveness, ease of use and safety of five machines for blood salvage during coronary artery surgery. All were equally effective in concentrating red cells. We measured haemoglobin, packed cell volume, free haemoglobin, white cells, neutrophil elastase, platelets, thrombin-antithrombin complex (TAT), prothrombin activation peptide F1.2, fibrin degradation product (d-dimers), tissue plasminogen activator (tPA) and heparin in wound blood, in washed cell suspensions and in a unit of bank blood prepared for each patient. All machines were equally safe and easy to use and were equally effective in removing heparin and the physiological components measured. There were no adverse effects on patients. Clotting factors are severely depleted both in salvaged blood, even before washing, and in bank blood. Cell savers are a valuable adjunct to coronary artery surgery, but careful monitoring of coagulation is required when the volumes of either bank blood or salvaged blood are large.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12071873     DOI: 10.1046/j.1365-3148.2002.00369.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  2 in total

Review 1.  Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-01-23       Impact factor: 2.300

2.  Washing older blood units before transfusion reduces plasma iron and improves outcomes in experimental canine pneumonia.

Authors:  Irene Cortés-Puch; Dong Wang; Junfeng Sun; Steven B Solomon; Kenneth E Remy; Melinda Fernandez; Jing Feng; Tamir Kanias; Landon Bellavia; Derek Sinchar; Andreas Perlegas; Michael A Solomon; Walter E Kelley; Mark A Popovsky; Mark T Gladwin; Daniel B Kim-Shapiro; Harvey G Klein; Charles Natanson
Journal:  Blood       Date:  2013-12-23       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.